Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
Background. Although drug-eluting stents (DES) have reduced the rates of in-stent restenosis (ISR) compared with bare-metal stents (BMS), DES related ISR (DES-ISR) still occurs and outcomes of DES-ISR remain unclear. The objective of this meta-analysis was to investigate the long-term clinical outco...
Saved in:
| Main Authors: | Yi-Xing Yang, Yin Liu, Chang-Ping Li, Peng-Ju Lu, Jiao Wang, Jing Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2020/8179849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01) -
Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01) -
Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)